FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383368809> ?p ?o ?g. }

• W4383368809 abstract "Abstract Background Diabetic nephropathy (DN) is a chronic condition resulting from microangiopathy in a high-glucose environment. The evaluation of vascular injury in DN has primarily focused on active molecules of VEGF, namely VEGFA and VEGF2(F2R). Notoginsenoside R1 (NGR1), a traditional anti-inflammatory medication, exhibits vascular activity. Therefore, identifying classical drugs with vascular inflammatory protection for the treatment of DN is a valuable pursuit. Methods The “Limma” method was employed to analyze the glomerular transcriptome data, while the Spearman algorithm for Swiss target prediction was utilized to analyze the drug targets of NGR1. The molecular docking technique was employed to investigate the relationship between vascular active drug targets, and the COIP experiment was conducted to verify the interaction between fibroblast growth factor 1 (FGF1) and VEGFA in relation to NGR1 and drug targets. Results According to the Swiss target prediction, the LEU32(b) site of the Vascular Endothelial Growth Factor A (VEGFA) protein, as well as the Lys112(a), SER116(a), and HIS102(b) sites of the Fibroblast Growth Factor 1 (FGF1) protein, are potential binding sites for NGR1 through hydrogen bonding. Additionally, the Co-immunoprecipitation (COIP) results suggest that VEGFA and FGF1 proteins can interact with each other, and NGR1 can impede this interaction. Furthermore, NGR1 can suppress the expression of VEGFA and FGF1 in a high-glucose environment, thereby decelerating podocyte apoptosis. Conclusion The inhibition of the interaction between FGF1 and VEGFA by NGR1 has been observed to decelerate podocyte apoptosis." @default.
• W4383368809 created "2023-07-07" @default.
• W4383368809 creator A5021019207 @default.
• W4383368809 creator A5023519725 @default.
• W4383368809 creator A5024693945 @default.
• W4383368809 creator A5030035442 @default.
• W4383368809 creator A5034020199 @default.
• W4383368809 creator A5062680050 @default.
• W4383368809 creator A5079086272 @default.
• W4383368809 date "2023-07-06" @default.
• W4383368809 modified "2023-09-26" @default.
• W4383368809 title "Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis" @default.
• W4383368809 cites W2128160632 @default.
• W4383368809 cites W2532136135 @default.
• W4383368809 cites W2610949836 @default.
• W4383368809 cites W2737074341 @default.
• W4383368809 cites W2898779065 @default.
• W4383368809 cites W2909189078 @default.
• W4383368809 cites W2998735913 @default.
• W4383368809 cites W3004206133 @default.
• W4383368809 cites W3009494702 @default.
• W4383368809 cites W3113809608 @default.
• W4383368809 cites W3164226385 @default.
• W4383368809 cites W3198639782 @default.
• W4383368809 cites W3205563176 @default.
• W4383368809 cites W3216854925 @default.
• W4383368809 cites W4200024642 @default.
• W4383368809 cites W4206799195 @default.
• W4383368809 cites W4220711829 @default.
• W4383368809 cites W4225724626 @default.
• W4383368809 cites W4280652278 @default.
• W4383368809 cites W4281485160 @default.
• W4383368809 cites W4281778630 @default.
• W4383368809 cites W4282917050 @default.
• W4383368809 cites W4283796254 @default.
• W4383368809 cites W4296098890 @default.
• W4383368809 cites W4309724059 @default.
• W4383368809 cites W4319984953 @default.
• W4383368809 doi "https://doi.org/10.1186/s12902-023-01402-6" @default.
• W4383368809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37415174" @default.
• W4383368809 hasPublicationYear "2023" @default.
• W4383368809 type Work @default.
• W4383368809 citedByCount "0" @default.
• W4383368809 crossrefType "journal-article" @default.
• W4383368809 hasAuthorship W4383368809A5021019207 @default.
• W4383368809 hasAuthorship W4383368809A5023519725 @default.
• W4383368809 hasAuthorship W4383368809A5024693945 @default.
• W4383368809 hasAuthorship W4383368809A5030035442 @default.
• W4383368809 hasAuthorship W4383368809A5034020199 @default.
• W4383368809 hasAuthorship W4383368809A5062680050 @default.
• W4383368809 hasAuthorship W4383368809A5079086272 @default.
• W4383368809 hasBestOaLocation W43833688091 @default.
• W4383368809 hasConcept C126322002 @default.
• W4383368809 hasConcept C134018914 @default.
• W4383368809 hasConcept C146285616 @default.
• W4383368809 hasConcept C159110408 @default.
• W4383368809 hasConcept C167734588 @default.
• W4383368809 hasConcept C170493617 @default.
• W4383368809 hasConcept C185592680 @default.
• W4383368809 hasConcept C190283241 @default.
• W4383368809 hasConcept C191709040 @default.
• W4383368809 hasConcept C2777025900 @default.
• W4383368809 hasConcept C2777146197 @default.
• W4383368809 hasConcept C2779561371 @default.
• W4383368809 hasConcept C2779922275 @default.
• W4383368809 hasConcept C2780091579 @default.
• W4383368809 hasConcept C41685203 @default.
• W4383368809 hasConcept C49418065 @default.
• W4383368809 hasConcept C502942594 @default.
• W4383368809 hasConcept C55493867 @default.
• W4383368809 hasConcept C555293320 @default.
• W4383368809 hasConcept C71924100 @default.
• W4383368809 hasConcept C74373430 @default.
• W4383368809 hasConcept C82867764 @default.
• W4383368809 hasConcept C86803240 @default.
• W4383368809 hasConcept C95444343 @default.
• W4383368809 hasConcept C98274493 @default.
• W4383368809 hasConceptScore W4383368809C126322002 @default.
• W4383368809 hasConceptScore W4383368809C134018914 @default.
• W4383368809 hasConceptScore W4383368809C146285616 @default.
• W4383368809 hasConceptScore W4383368809C159110408 @default.
• W4383368809 hasConceptScore W4383368809C167734588 @default.
• W4383368809 hasConceptScore W4383368809C170493617 @default.
• W4383368809 hasConceptScore W4383368809C185592680 @default.
• W4383368809 hasConceptScore W4383368809C190283241 @default.
• W4383368809 hasConceptScore W4383368809C191709040 @default.
• W4383368809 hasConceptScore W4383368809C2777025900 @default.
• W4383368809 hasConceptScore W4383368809C2777146197 @default.
• W4383368809 hasConceptScore W4383368809C2779561371 @default.
• W4383368809 hasConceptScore W4383368809C2779922275 @default.
• W4383368809 hasConceptScore W4383368809C2780091579 @default.
• W4383368809 hasConceptScore W4383368809C41685203 @default.
• W4383368809 hasConceptScore W4383368809C49418065 @default.
• W4383368809 hasConceptScore W4383368809C502942594 @default.
• W4383368809 hasConceptScore W4383368809C55493867 @default.
• W4383368809 hasConceptScore W4383368809C555293320 @default.
• W4383368809 hasConceptScore W4383368809C71924100 @default.
• W4383368809 hasConceptScore W4383368809C74373430 @default.
• W4383368809 hasConceptScore W4383368809C82867764 @default.
• W4383368809 hasConceptScore W4383368809C86803240 @default.

• next